Tilray Brands (TLRY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Eupraxia Pharmaceuticals Inc. (EPRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Anthony Albanese had Jim Chalmers draw up a new superannuation policy due to fears of a scare campaign against Labor, and the ...

Grocery Outlet Holding Corp. (GO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings ...

ABB (ABBNY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...

In every bull cycle, investors face the same question: stick with established names that have already delivered historic ...

Introduction Previous trauma and adverse life experiences have been hypothesised to be aetiological factors for functional neurological disorder (FND) leading to the hypothesis of a ‘trauma-subtype’ ...

Americans are more ingredient-conscious than ever before — but not in all areas, according to new research. A survey ...

Schwab U.S. Dividend Equity ETF is an incredibly popular but controversial dividend ETF with $69 billion in AUM. Learn more ...

Schwab U.S. Dividend Equity ETF offers strong downside protection, steady income, and low volatility—ideal for conservative ...

Coronary artery calcium (CAC) is a marker of subclinical atherosclerosis that confers increased risk of atherosclerotic cardiovascular disease. Measured by noncontrast cardiac computed tomography, CAC ...

The authors describe an interesting approach to studying the dynamics and function of membrane proteins in different lipid environments. The important findings have theoretical and practical ...